美股A股
StockGist
Back
10-Q2026-05-15· grok-4-1-fast-non-reasoning

ATER · Aterian, Inc.

0001437749-26-017437

SEC filing

Summary

Consolidated revenue collapsed 99.9% YoY to $18K as marquee brands shifted to discontinued operations ahead of asset sale, leaving a minimal continuing base with improved operating loss but widened net loss amid macroeconomic pressures.

Key takeaways

Full analysis

Revenue from continuing operations plummeted 99.9% year-over-year to $18 thousand in Q1 FY2026 from $15.4 million, as the Company transitioned marquee brands to discontinued operations in preparation for an anticipated asset sale. This dramatic shift left a small base of legacy brands like Vremi and Xtava, directly reflecting management's strategic pivot. The steep decline aligns with business drivers cited in MD&A: pricing actions to counter costs contributed to lower unit volumes, while the broader macroeconomic environment reduced consumer demand, softening sales at elevated price levels.

Gross profit mirrored the revenue trajectory, dropping 99.9% to $10 thousand from $9.4 million, but achieved a robust 55.6% gross margin—up significantly from prior periods. This expansion stems from a favorable mix shift toward products with lower fulfillment costs as a percentage of net revenue, allowing maintenance of targeted profitability even at reduced scale. Management notes that such products can sustain lower margins while others require higher ones to offset elevated fulfillment expenses, a dynamic now prominent post-divestiture.

Operating income improved 13.2% to a loss of -$3.2 million from -$3.7 million, demonstrating cost discipline in a shrunken revenue environment. Operating margin, while deeply negative at -17,828%, reflects the fixed cost burden on minimal topline. Net income deteriorated 57.4% to -$6.1 million from -$3.9 million, underscoring ongoing challenges despite operational progress.

Cash flow from operations strengthened markedly to a use of -$363 thousand from -$3.9 million, aided by working capital efficiencies versus prior outflows from receivables, inventory purchases, and payables. Free cash flow was -$367 thousand after $4 thousand in capex—minimal versus zero last year—prioritizing preservation amid liquidity squeeze. Supply chain disruptions continue to risk higher inventory holds, straining working capital and necessitating warehouse expansions with capital implications. Global freight issues may further elevate COGS and operating expenses.

Post-asset sale, focus shifts to streamlining remaining brands, with inventory valued at net realizable value based on expected selling prices less disposal costs when needed. Management has de-emphasized historical non-GAAP metrics like Adjusted EBITDA, deeming them unrepresentative of ongoing performance in this restructured profile. These dynamics position the continuing business for disciplined execution amid macroeconomic headwinds.